[Expression of type VI collagen in arthrofibrosis. An immunohistochemical study]
- PMID: 10986907
- DOI: 10.1007/s001130050597
[Expression of type VI collagen in arthrofibrosis. An immunohistochemical study]
Abstract
Arthrofibrosis is a disabling complication after trauma and surgery due to massive connective tissue proliferation. The etiology and pathogenesis have never been fully understood. A strong immune response may lead to activation and proliferation of fibroblasts with excessive and disordered deposition of matrix proteins. In similar pathological conditions, like lung fibrosis or superficial fibromatoses with fibrotic transformation an increased expression of collagen type VI has been reported. We investigated fibrotic tissue samples taken from 18 patients (average age: 32.7 years), who underwent arthrolysis of the knee joint because of symptomatic arthrofibrosis following ligament injury. The mean interval between trauma and arthrolysis was 13.8 months (range 4-50 months). Tissue samples were taken from the infrapatellar fat pad and intercondylar connective tissue. All samples were stained with HE. The expression of type III and VI collagen was studied immunohistochemically using an immunoperoxidase method for light microscopic visualization. Histologic analysis from patients with arthrofibrosis showed a synovial hyperplasia with cell infiltration and vascular proliferation compared to synovial tissue samples from knee joints without any detectable pathology. Subsynovial an increased deposition of matrix proteins was visible. Type VI collagen was widely distributed as a network subsynovial and around capillary walls. Type III collagen showed a diffuse distribution. Arthrofibrotic tissue is, similar to pathological conditions with fibrotic transformation characterized by an increased expression of collagen type VI. Collagen type VI may play an important role in matrix homeostasis. It serves as an anchoring element between collagen fibers and as a cell binding structure.
Similar articles
-
Immunohistochemical localization of collagen VI in arthrofibrosis.Arch Orthop Trauma Surg. 1999;119(5-6):315-8. doi: 10.1007/s004020050417. Arch Orthop Trauma Surg. 1999. PMID: 10447630 Clinical Trial.
-
[Localisation of TGF-beta and PDGF and their relevance for the pathogenesis of arthrofibrosis].Unfallchirurg. 2008 Feb;111(2):79-84. doi: 10.1007/s00113-008-1407-y. Unfallchirurg. 2008. PMID: 18239901 German.
-
[Intrinsic properties of arthrofibrosis tissue: histologic and cell biology analysis].Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):189-91. Langenbecks Arch Chir Suppl Kongressbd. 1998. PMID: 14518240 German.
-
[Arthrofibrosis].Orthopade. 2002 Aug;31(8):785-90. doi: 10.1007/s00132-002-0336-7. Orthopade. 2002. PMID: 12426757 Review. German.
-
Blocking fibrotic signaling in fibroblasts from patients with carpal tunnel syndrome.J Cell Physiol. 2018 Mar;233(3):2067-2074. doi: 10.1002/jcp.25901. Epub 2017 May 3. J Cell Physiol. 2018. PMID: 28294324 Free PMC article. Review.
Cited by
-
Human xylosyltransferases--mediators of arthrofibrosis? New pathomechanistic insights into arthrofibrotic remodeling after knee replacement therapy.Sci Rep. 2015 Jul 28;5:12537. doi: 10.1038/srep12537. Sci Rep. 2015. PMID: 26219087 Free PMC article.
-
[The surgical treatment of chronic extension deficits of the knee].Oper Orthop Traumatol. 2009 Dec;21(6):545-56. doi: 10.1007/s00064-009-2004-0. Oper Orthop Traumatol. 2009. PMID: 20087716 Clinical Trial. German.
-
[Therapy of arthrofibrosis after total knee arthroplasty].Orthopade. 2006 Feb;35(2):143-52. doi: 10.1007/s00132-005-0915-5. Orthopade. 2006. PMID: 16374640 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical